AUTUMN DITTENBER: Open Payments
NPI 1013461581 · FREMONT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 21 payments from 6 companies in 2025. Trend: 2023 $232 · 2024 $1,568 · 2025 $874
Food & beverage: $764Education: $109
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $226 |
| Axsome Therapeutics, Inc. | 5 | $195 |
| Teva Pharmaceuticals USA, Inc. | 3 | $163 |
| Lundbeck LLC | 4 | $133 |
| Alkermes, Inc. | 1 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
Products named: REXULTI, Auvelity, LYBALVI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across MI — which companies pay providers there.
